Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FAAH inhibitors(Anandamide amidohydrolase inhibitors), MAGL inhibitors(Monoglyceride lipase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | DK | 01 Nov 2024 | |
Mantle-Cell Lymphoma | Preclinical | DK | 01 Nov 2024 |